Certain Ordinary Shares of Poly Medicure Limited are subject to a Lock-Up Agreement Ending on 18-AUG-2021.
August 17, 2021
Share
Certain Ordinary Shares of Poly Medicure Limited are subject to a Lock-Up Agreement Ending on 18-AUG-2021. These Ordinary Shares will be under lockup for 180 days starting from 19-FEB-2021 to 18-AUG-2021.
Details:
The Company and the Promoters will not, for a period commencing from the date of Allotment and ending 180 days from the date of Allotment, without the prior written consent of the Book Running Lead Managers, offer, issue, pledge, sell, encumber, contract to sell or announce the intention to sell, lend, purchase any option or contract to sell, grant or sell any option, right, contract or warrant to purchase, lend, make any short sale or otherwise transfer or dispose of any Equity Shares or Lock-up Shares, enter into any swap or other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequences of ownership of the Shares, enter into any transaction (including a transaction involving derivatives) having an economic effect similar to that of an issue, offer, sale or deposit of the Shares in any depository receipt facility and publicly announce its intention to enter into the transactions referred to above.
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
POLY MEDICURE LIMITED 
